Diabetes.co.uk

Last updated
Diabetes.co.uk
Diabetescouklogo.gif
Type of business Private
Type of site
Social networking, Internet forum, Community site
Founded2001
Headquarters,
Key peopleArjun Panesar
Charlotte Summers
Barry Summers
URL diabetes.co.uk
LaunchedApril 1, 2003
Current statusActive

Diabetes.co.uk is a British-based website that offers news, information and resources on diabetes, describing itself as "Europe's largest community of people with diabetes". [1]

Contents

The Diabetes Forum, is a patient network that aims to improve the health of people with diabetes, [2] with a stated goal of connecting people with diabetes and providing a platform for diabetics to share their experiences, managing diabetes, and the associated complications.

History

Diabetes.co.uk was founded in 2003, by Arjun Panesar after his grandfather was diagnosed with type 2 diabetes. [3]

In March 2014, Diabetes.co.uk launched the hashtag #BloodSugarSelfie to raise awareness for diabetes through people posting selfies with their blood glucose readings. Promoted through social media, the campaign raised money for JDRF UK and was reported to have saved a life. [4] In October 2015, the #BloodSugarSelfie campaign was recognised for the Best use of social media to deliver a health campaign. [5]

The organisation runs the Diabetes Awareness Month each November in the UK, having done so since 2015. [6]

Growth

The Diabetes Forum is Europe's largest diabetes forum. [7]

Diabetes.co.uk was recognised as 'game-changing disruptors' in 2017's Maserati 100, an annual list published jointly between Maserati and The Sunday Times which celebrates and recognises "innovative entrepreneurs". [8] [9]

Products and services

Publishing

Diabetes.co.uk publishes news, videos and information on diabetes and related industries daily.[ citation needed ]

Books

Reverse Your Diabetes: The Step-by-Step Plan to Take Control of Type 2 Diabetes is written by Dr David Cavan, ex-Director of Policy and Programmes at the International Diabetes Federation (IDF) and published by Random House. [10] A second book, Reverse Your Diabetes Diet: The new eating plan to take control of type 2 diabetes, with 60 quick-and-easy recipes was published in March 2016.

Diabetes Forum

The Diabetes Forum is Europe's largest forum dedicated to diabetes. [7]

In 2013, the forum was recognised by the UK Quality in Care (QiC) Awards Programme for improving self-management and diabetes care through social interaction. [11]

The forum was cited as being popular in highlighting the adoption of a low carbohydrate diet as a way of achieving weight loss and improving HbA1c in patients with Type 2 Diabetes, despite the approach being 'generally frowned upon in the UK'. [12]

Related Research Articles

<span class="mw-page-title-main">Carbohydrate</span> Organic compound that consists only of carbon, hydrogen, and oxygen

A carbohydrate is a biomolecule consisting of carbon (C), hydrogen (H) and oxygen (O) atoms, usually with a hydrogen–oxygen atom ratio of 2:1 and thus with the empirical formula Cm(H2O)n, which does not mean the H has covalent bonds with O. However, not all carbohydrates conform to this precise stoichiometric definition, nor are all chemicals that do conform to this definition automatically classified as carbohydrates.

The following is a glossary of diabetes which explains terms connected with diabetes.

<span class="mw-page-title-main">Hyperglycemia</span> Too much blood sugar, usually because of diabetes

Hyperglycemia is a condition in which an excessive amount of glucose circulates in the blood plasma. This is generally a blood sugar level higher than 11.1 mmol/L (200 mg/dL), but symptoms may not start to become noticeable until even higher values such as 13.9–16.7 mmol/L (~250–300 mg/dL). A subject with a consistent range between ~5.6 and ~7 mmol/L is considered slightly hyperglycemic, and above 7 mmol/L is generally held to have diabetes. For diabetics, glucose levels that are considered to be too hyperglycemic can vary from person to person, mainly due to the person's renal threshold of glucose and overall glucose tolerance. On average, however, chronic levels above 10–12 mmol/L (180–216 mg/dL) can produce noticeable organ damage over time.

<span class="mw-page-title-main">Type 2 diabetes</span> Type of diabetes mellitus with high blood sugar and insulin resistance

Type 2 diabetes, formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, and unexplained weight loss. Symptoms may also include increased hunger, feeling tired, and sores (wounds) that do not heal. Often symptoms come on slowly. Long-term complications from high blood sugar include heart disease, strokes, diabetic retinopathy which can result in blindness, kidney failure, and poor blood flow in the limbs which may lead to amputations. The sudden onset of hyperosmolar hyperglycemic state may occur; however, ketoacidosis is uncommon.

<span class="mw-page-title-main">Low-carbohydrate diet</span> Diets restricting carbohydrate consumption

Low-carbohydrate diets restrict carbohydrate consumption relative to the average diet. Foods high in carbohydrates are limited, and replaced with foods containing a higher percentage of fat and protein, as well as low carbohydrate foods.

<span class="mw-page-title-main">Acarbose</span> Chemical compound

Acarbose (INN) is an anti-diabetic drug used to treat diabetes mellitus type 2 and, in some countries, prediabetes. It is a generic sold in Europe and China as Glucobay, in North America as Precose, and in Canada as Prandase. It is cheap and popular in China, but not in the U.S. One physician explains the use in the U.S. is limited because it is not potent enough to justify the side effects of diarrhea and flatulence. However, a large study concluded in 2013 that "acarbose is effective, safe and well tolerated in a large cohort of Asian patients with type 2 diabetes." A possible explanation for the differing opinions is an observation that acarbose is significantly more effective in patients eating a relatively high carbohydrate Eastern diet.

Glycated hemoglobin is a form of hemoglobin (Hb) that is chemically linked to a sugar. Most monosaccharides, including glucose, galactose and fructose, spontaneously bond with hemoglobin when present in the bloodstream. However, glucose is less likely to do so than galactose and fructose, which may explain why glucose is used as the primary metabolic fuel in humans.

Diabetes is a chronic disease in cats whereby either insufficient insulin response or insulin resistance leads to persistently high blood glucose concentrations. Diabetes affects up to 1 in 230 cats, and may be becoming increasingly common. Diabetes is less common in cats than in dogs. Eighty to ninety-five percent of diabetic cats experience something similar to type 2 diabetes but are generally severely insulin dependent by the time symptoms are diagnosed. The condition is treatable, and if treated properly the cat can experience a normal life expectancy. In cats with type 2 diabetes, prompt effective treatment may lead to diabetic remission, in which the cat no longer needs injected insulin. Untreated, the condition leads to increasingly weak legs in cats and eventually to malnutrition, ketoacidosis and/or dehydration, and death.

JDRF is a nonprofit 501(c)(3) organization that funds type 1 diabetes (T1D) research, provides a broad array of community and activist services to the T1D population and actively advocates for regulation favorable to medical research and approval of new and improved treatment modalities. It was initially founded as the JDF, the Juvenile Diabetes Foundation. It later changed its name to the Juvenile Diabetes Research Foundation and is now known as JDRF.

The term diabetes includes several different metabolic disorders that all, if left untreated, result in abnormally high concentrations of a sugar called glucose in the blood. Diabetes mellitus type 1 results when the pancreas no longer produces significant amounts of the hormone insulin, usually owing to the autoimmune destruction of the insulin-producing beta cells of the pancreas. Diabetes mellitus type 2, in contrast, is now thought to result from autoimmune attacks on the pancreas and/or insulin resistance. The pancreas of a person with type 2 diabetes may be producing normal or even abnormally large amounts of insulin. Other forms of diabetes mellitus, such as the various forms of maturity-onset diabetes of the young, may represent some combination of insufficient insulin production and insulin resistance. Some degree of insulin resistance may also be present in a person with type 1 diabetes.

Alpha-glucosidase inhibitors (AGIs) are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of carbohydrates. Carbohydrates are normally converted into simple sugars (monosaccharides) by alpha-glucosidase enzymes present on cells lining the intestine, enabling monosaccharides to be absorbed through the intestine. Hence, alpha-glucosidase inhibitors reduce the impact of dietary carbohydrates on blood sugar.

Automated insulin delivery systems are automated systems designed to assist people with insulin-requiring diabetes, by automatically adjusting insulin delivery in response to blood glucose levels. Currently available systems can only deliver a single hormone—insulin. Other systems currently in development aim to improve on current systems by adding one or more additional hormones that can be delivered as needed, providing something closer to the endocrine functionality of the pancreas.

A diabetic diet is a diet that is used by people with diabetes mellitus or high blood sugar to minimize symptoms and dangerous complications of long-term elevations in blood sugar.

<span class="mw-page-title-main">Diabetes management software</span>

Diabetes Management Software refers to software tools that run on personal computers and personal digital assistants to help persons with Type 1 and Type 2 diabetes manage the data associated with:

Richard K. Bernstein is a physician and an advocate for a low-carbohydrate diabetes diet to help achieve normal blood sugars for diabetics. Bernstein has type 1 diabetes. His private medical practice in Mamaroneck, New York is devoted solely to treating diabetes and prediabetes.

<span class="mw-page-title-main">Prediabetes</span> Predisease state of hyperglycemia with high risk for diabetes

Prediabetes is a component of the metabolic syndrome and is characterized by elevated blood sugar levels that fall below the threshold to diagnose diabetes mellitus. It usually does not cause symptoms but people with prediabetes often have obesity, dyslipidemia with high triglycerides and/or low HDL cholesterol, and hypertension. It is also associated with increased risk for cardiovascular disease (CVD). Prediabetes is more accurately considered an early stage of diabetes as health complications associated with type 2 diabetes often occur before the diagnosis of diabetes.

Prevention of type 2 diabetes can be achieved with both lifestyle changes and use of medication. The American Diabetes Association categorizes prediabetes as a high-risk group that has glycemic levels higher than normal but does not meet criteria for diabetes. Without intervention people with prediabetes progress to type 2 diabetes with a 5% to 10% rate. Diabetes prevention is achieved through weight loss and increased physical activity, which can reduce the risk of diabetes by 50% to 60%.

The following outline is provided as an overview of and topical guide to diabetes mellitus :

<span class="mw-page-title-main">Diabetes</span> Medical condition

Diabetes, also known as diabetes mellitus, is a group of common endocrine diseases characterized by sustained high blood sugar levels. Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. Diabetes, if left untreated, leads to many health complications. Untreated or poorly treated diabetes accounts for approximately 1.5 million deaths per year.

<i>Pure, White and Deadly</i> 1972 book by John Yudkin on the damages caused by the increase in sugar consumption

Pure, White and Deadly is a 1972 book by John Yudkin, a British nutritionist and former Chair of Nutrition at Queen Elizabeth College, London. Published in New York, it was the first publication by a scientist to anticipate the adverse health effects, especially in relation to obesity and heart disease, of the public's increased sugar consumption. At the time of publication, Yudkin sat on the advisory panel of the British Department of Health's Committee on the Medical Aspects of Food and Nutrition Policy (COMA). He stated his intention in writing the book in the last paragraph of the first chapter: "I hope that when you have read this book I shall have convinced you that sugar is really dangerous."

References

  1. "Diabetes.co.uk is a community website focusing on providing a comprehensive, supportive and independent experience for our visitors from across the world". Diabetes. 2019-01-15. Retrieved 2020-09-08.
  2. Diabetes.co.uk profile
  3. "Meet The Tech Company Looking To Reverse Type 2 Diabetes In 10 Million People". Forbes . Archived from the original on 2023-05-10.
  4. #BloodSugarSelfie saved my life says JDRF supporter
  5. #Bloodsugarselfie - Best use of social media to deliver a health campaign
  6. Diabetes Times: Diabetes Awareness Month kicks off
  7. 1 2 Diabetes Times: Diabetes.co.uk reaches over 100,000 members
  8. Maserati 100: Diabetes.co.uk - Arjun Panesar and Charlotte Summers
  9. Diabetes.co.uk founders make Sunday Times ‘disruptor’ list
  10. Cavan, David. Reverse Your Diabetes: The Step-by-Step Plan to Take Control of Type 2 Diabetes.
  11. Quality in Care Programme: Best initiative supporting self-care
  12. Unwin, David; Unwin, Jen (2014). "Low carbohydrate diet to achieve weight loss and improve HbA1c in type 2 diabetes and pre-diabetes: experience from one general practice". Practical Diabetes. 31 (2): 76–79. doi:10.1002/pdi.1835. ISSN   2047-2897.